Genetic and Clinical Characteristics of 24 Mainland Chinese Patients with CTNNB1 Loss-of-function Variants

Overview

Journal Mol Genet Genomic Med

Specialty Genetics

Date 2022 Sep 25

PMID 36153650

Authors

Dan Yan

Yu Sun

Na Xu

Yongguo Yu

Yongkun Zhan

Affiliations

Soon will be listed here.

Abstract

Background: Neurodevelopmental disorder with spastic diplegia and visual defects (NEDSDV) is a rare autosomal dominant syndrome, which is caused by the heterozygous germline loss-of-function variants in CTNNB1.

Methods: We evaluated the clinical and genetic findings of 24 previously undescribed Chinese patients affected by CTNNB1-related disorders and explored the possible ethnicity-related phenotypic variations.

Results: Twenty-one loss-of-function variants were identified within these 24 NEDSDV patients, including 14 novel CTNNB1 variants and 7 recurrent ones. The prominent clinical manifestations in our cohort are developmental delay/intellectual disability (100%), motor delay (100%), speech impairment (100%), dystonia (87.5%) and microcephaly (69.6%). The common facial dysmorphisms were consistent with previous reports, including wide nasal bridge (58.3%), bulbous nose (45.8%), long philtrum (45.8%) and thin upper lip (45.8%). In addition, 19 patients (79.2%) in our cohort had mild visual defects, while one affected individual (4.2%) had familial exudative vitreoretinopathy. Notably, we discovered that 20 patients (83.3%) exhibited various behavioral abnormalities, which is described in Chinese patients for the first time.

Conclusion: We provided the largest known Chinese cohort with pathogenic CTNNB1 variants, which not only helps to expand the variant spectrum of CTNNB1 gene, but further delineates the typical phenotype of this disorder in Chinese population.

Citing Articles

Familial exudative vitreoretinopathy caused by CTNNB1 gene de novo mutation in a Chinese family: a case report.

Wang Y, Chang Y, Lei H, Yan W, Chai Y, Zang W BMC Pediatr. 2025; 25(1):146.

PMID: 40011896 PMC: 11863797. DOI: 10.1186/s12887-025-05508-9.

Clinical phenotypic spectrum of CTNNB1 neurodevelopmental disorder.

Sudnawa K, Garber A, Cohen R, Calamia S, Kanner C, Montes J Clin Genet. 2024; 105(5):523-532.

PMID: 38247296 PMC: 11872165. DOI: 10.1111/cge.14487.

Neurodegeneration-associated protein VAPB regulates proliferation in medulloblastoma.

Assoni A, Mitsugi T, Wardenaar R, Ferreira R, Jandrey E, Novaes G Sci Rep. 2023; 13(1):19481.

PMID: 37945695 PMC: 10636017. DOI: 10.1038/s41598-023-45319-5.

From Feeding Challenges to Oral-Motor Dyspraxia: A Comprehensive Description of 10 New Cases with CTNNB1 Syndrome.

Onesimo R, Sforza E, Trevisan V, Leoni C, Giorgio V, Rigante D Genes (Basel). 2023; 14(10).

PMID: 37895192 PMC: 10606760. DOI: 10.3390/genes14101843.

Molecular Subtype Classification of Postmenopausal Osteoporosis and Immune Infiltration Microenvironment Based on Bioinformatics Analysis of Osteoclast-Regulatory Genes.

Gong Y, Hao D, Zhang Y, Tu Y, He B, Yan L Biomedicines. 2023; 11(10).

PMID: 37893075 PMC: 10604900. DOI: 10.3390/biomedicines11102701.

References

ORoak B, Vives L, Girirajan S, Karakoc E, Krumm N, Coe B . Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations. Nature. 2012; 485(7397):246-50. PMC: 3350576. DOI: 10.1038/nature10989. View

Dixon M, Stem M, Schuette J, Keegan C, Besirli C . CTNNB1 mutation associated with familial exudative vitreoretinopathy (FEVR) phenotype. Ophthalmic Genet. 2016; 37(4):468-470. DOI: 10.3109/13816810.2015.1120318. View

Dong F, Jiang J, McSweeney C, Zou D, Liu L, Mao Y . Deletion of CTNNB1 in inhibitory circuitry contributes to autism-associated behavioral defects. Hum Mol Genet. 2016; 25(13):2738-2751. PMC: 5181638. DOI: 10.1093/hmg/ddw131. View

Tucci V, Kleefstra T, Hardy A, Heise I, Maggi S, Willemsen M . Dominant β-catenin mutations cause intellectual disability with recognizable syndromic features. J Clin Invest. 2014; 124(4):1468-82. PMC: 3973091. DOI: 10.1172/JCI70372. View

Taylor R, Soriano C, Williams S, Dzulova D, Ashworth J, Hall G . Bi-allelic mutation of CTNNB1 causes a severe form of syndromic microphthalmia, persistent foetal vasculature and vitreoretinal dysplasia. Orphanet J Rare Dis. 2022; 17(1):110. PMC: 8896279. DOI: 10.1186/s13023-022-02239-3. View

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J . Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015; 17(5):405-24. PMC: 4544753. DOI: 10.1038/gim.2015.30. View

Ke Z, Chen Y . Case Report: A CTNNB1 Nonsense Mutation Associated With Neurodevelopmental Disorder, Retinal Detachment, Polydactyly. Front Pediatr. 2021; 8:575673. PMC: 7793974. DOI: 10.3389/fped.2020.575673. View

Wickham R, Alexander J, Eden L, Valencia-Yang M, Llamas J, Aubrey J . Learning impairments and molecular changes in the brain caused by β-catenin loss. Hum Mol Genet. 2019; 28(17):2965-2975. PMC: 6736100. DOI: 10.1093/hmg/ddz115. View

Panagiotou E, Sanjurjo Soriano C, Poulter J, Lord E, Dzulova D, Kondo H . Defects in the Cell Signaling Mediator β-Catenin Cause the Retinal Vascular Condition FEVR. Am J Hum Genet. 2017; 100(6):960-968. PMC: 5473728. DOI: 10.1016/j.ajhg.2017.05.001. View

10.

Kharbanda M, Pilz D, Tomkins S, Chandler K, Saggar A, Fryer A . Clinical features associated with CTNNB1 de novo loss of function mutations in ten individuals. Eur J Med Genet. 2016; 60(2):130-135. PMC: 6070129. DOI: 10.1016/j.ejmg.2016.11.008. View

11.

Piven O, Winata C . The canonical way to make a heart: β-catenin and plakoglobin in heart development and remodeling. Exp Biol Med (Maywood). 2017; 242(18):1735-1745. PMC: 5714149. DOI: 10.1177/1535370217732737. View

12.

Xu W, Kimelman D . Mechanistic insights from structural studies of beta-catenin and its binding partners. J Cell Sci. 2007; 120(Pt 19):3337-44. DOI: 10.1242/jcs.013771. View

13.

Wang H, Zhao Y, Yang L, Han S, Qi M . Identification of a novel splice mutation in CTNNB1 gene in a Chinese family with both severe intellectual disability and serious visual defects. Neurol Sci. 2019; 40(8):1701-1704. PMC: 6647480. DOI: 10.1007/s10072-019-03823-5. View

14.

Kuechler A, Willemsen M, Albrecht B, Bacino C, Bartholomew D, van Bokhoven H . De novo mutations in beta-catenin (CTNNB1) appear to be a frequent cause of intellectual disability: expanding the mutational and clinical spectrum. Hum Genet. 2014; 134(1):97-109. DOI: 10.1007/s00439-014-1498-1. View

15.

Wang Z, Liu C, Huang S, Chen J . Wnt Signaling in vascular eye diseases. Prog Retin Eye Res. 2018; 70:110-133. PMC: 6545170. DOI: 10.1016/j.preteyeres.2018.11.008. View

16.

Ho S, Tsang M, Fung J, Huang H, Chow C, Cheng S . CTNNB1-related neurodevelopmental disorder in a Chinese population: A case series. Am J Med Genet A. 2021; 188(1):130-137. DOI: 10.1002/ajmg.a.62504. View

17.

Rossetti L, Bekheirnia M, Lewis A, Mefford H, Golden-Grant K, Tarczy-Hornoch K . Missense variants in CTNNB1 can be associated with vitreoretinopathy-Seven new cases of CTNNB1-associated neurodevelopmental disorder including a previously unreported retinal phenotype. Mol Genet Genomic Med. 2020; 9(1):e1542. PMC: 7963417. DOI: 10.1002/mgg3.1542. View

18.

Yan D, Sun Y, Xu N, Yu Y, Zhan Y . Genetic and clinical characteristics of 24 mainland Chinese patients with CTNNB1 loss-of-function variants. Mol Genet Genomic Med. 2022; 10(11):e2067. PMC: 9651608. DOI: 10.1002/mgg3.2067. View

19.

Bian J, Dannappel M, Wan C, Firestein R . Transcriptional Regulation of Wnt/β-Catenin Pathway in Colorectal Cancer. Cells. 2020; 9(9). PMC: 7564852. DOI: 10.3390/cells9092125. View

20.

de Ligt J, Willemsen M, van Bon B, Kleefstra T, Yntema H, Kroes T . Diagnostic exome sequencing in persons with severe intellectual disability. N Engl J Med. 2012; 367(20):1921-9. DOI: 10.1056/NEJMoa1206524. View